The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss.
Tag: Novo Nordisk A/S
-
Where Ozempic, Wegovy and New Weight Loss Drugs Came From
The empty auditoriums, Gila monsters, resistant pharmaceutical executives and enigmas that led to Ozempic and other drugs that may change how society thinks about obesity.
-
Wegovy Cuts Risk of Heart Problems, Novo Nordisk Trial Says
A clinical trial was the first to demonstrate that a new obesity drug could also improve patients’ heart health.
-
An Ozempic Pill Is On the Horizon: What to Know
Research published Sunday evaluates the effectiveness of the active ingredient in injectable diabetes and obesity drugs when taken orally.
-
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.